The American College of Obstetricians and Gynecologists released a statement on robotic surgery this week that concluded:
Aggressive direct-to-consumer marketing of the latest medical technologies may mislead the public into believing that they are the best choice. Our patients deserve and need factual information about all of their treatment options, including costs, so that they can make truly informed health care decisions. Patients should be advised that robotic hysterectomy is best used for unusual and complex clinical conditions in which improved outcomes over standard minimally invasive approaches have been demonstrated.
You can read the full statement here.
You can also read past blog posts on robotic hysterectomy or other robotic surgery.